REGENXBIO Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
REGENXBIO Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • REGENXBIO Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.44M, a 10.2% decline year-over-year.
  • REGENXBIO Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $37.6M, a 9.11% decline year-over-year.
  • REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.3M, a 1.28% decline from 2022.
  • REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2022 was $40.8M, a 5.1% increase from 2021.
  • REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2021 was $38.8M, a 21.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $40.3M -$521K -1.28% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $40.8M +$1.98M +5.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $38.8M +$6.86M +21.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $31.9M +$5.1M +19% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $26.9M +$10.2M +61.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $16.6M +$6.04M +56.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $10.6M +$3.57M +50.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $7.03M +$4.11M +141% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $2.92M +$2.6M +816% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $319K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.